$NBIO recognizes this patent approval as a landmark event for the Company's value proposition. The approval strengthens the Company's intellectual property position significantly by providing protection that extends well beyond the Company's Orphan Drug Designation. https://finance.yahoo.com/news/nascent-biotech-earns-us-patent-130000301.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.